CDC recommends second dose of 2024-2025 coronavirus vaccine for people 65 and older and moderately or severely immunocompromised
(October 23) Centers for Disease Control and Prevention (CDC) Director Mandy Cohen urges CDC Immunization Practices Advisory Committee members to get second doses for people 65 and older and those with moderate or severe immunocompromise. ACIP supported the recommendations recommended by Data from 6 months after the first dose of the 2024-2025 novel coronavirus disease (COVID-19) vaccine. These updated recommendations also allow for flexibility in providing additional doses (i.e., 3 or more doses) for moderately or severely immunocompromised patients in consultation with healthcare providers (a strategy known as shared clinical decision-making). ).
“This vote will empower people to make the best decisions possible to protect themselves and their loved ones from COVID-19,” Cohen said. “CDC continues to educate the public about how and when to get the latest vaccinations to reduce their risk of serious illness and help them do more of the things they love.”
This recommendation, along with currently available data on vaccine effectiveness and the annual prevalence of COVID-19, acknowledges the increased risk of severe illness from COVID-19 in older people and immunocompromised individuals. The recommendations also provide clarity to health care providers about how many vaccinations per year should be given to moderately or severely immunocompromised patients and expand coverage of second vaccinations for that group. The purpose is to
Data continues to confirm the importance of vaccination to protect those most at risk of severe outcomes from COVID-19. Receive the recommended 2024-2025 coronavirus disease (COVID-19) vaccine to restore protection against virus variants currently causing most infections and hospitalizations in the United States and can be strengthened. COVID-19 vaccination also reduces the likelihood of long-term COVID-19 effects, which can develop during or after an acute infection and last for a long time.
CDC and ACIP will continue to monitor the safety and effectiveness of coronavirus vaccines. The CDC continues to recommend that everyone, especially those age 65 and older and those with compromised immune systems, stay informed about COVID-19 vaccines.
For more information about the latest COVID-19 vaccines, please visit: Coronavirus Disease 2019 (COVID-19) | CDC.
This news release was issued by the Centers for Disease Control and Prevention on October 23, 2024.
